Lineage Cell Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

리니지 셀 테라퓨틱스NYSEAMERICAN:LCTX · NYSE Amex · Healthcare · sector #16

$0.9379+1.13%

2026-10-06 close · prelim

Lineage Cell Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $9M. 2024 operating profit was −$21M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy